Predicting oral cephalosporin susceptibility in <i>Escherichia coli</i> blood isolates using parenteral cephalosporin susceptibility testing
Prediction of oral second-generation cephalosporins may warrant cefazolin MIC ≤2 mg/L, despite limitations regarding false resistance and susceptibility discordant. Ceftriaxone/cefotaxime demonstrates a more reliable surrogate for predicting oral third-generation cephalosporins susceptibility. Future investigations are necessary to clinically corroborate these findings.
Authors
- Vanthida Huang (ORCID: https://orcid.org/0000-0001-8028-3554)
- Tho H Pham (ORCID: https://orcid.org/0009-0007-2338-5491)
- Kyle C. Molina (ORCID: https://orcid.org/0000-0002-6764-5984)
Institutions
- Midwestern University (US)
- Scripps Health (US)
- University of Arizona (US)
- Scripps Mercy Hospital (US)
- Phoenix College (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1093/jac/dkag093
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 0.00